Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Mar 06, 2023 4:24pm
168 Views
Post# 35322233

RE:RE:RE:Quote by Warren Buffet

RE:RE:RE:Quote by Warren BuffetAs of now, there is no additional info that guarantees this raise will be at a better price than the last time, where they struggled to raise any money for a month and then closed it with a paltry amount bought by insiders.  Why would investors buy anything this time without a material update first?   If the BTD is imminent, wouldn't you as the CEO wait till that happens before raising money?  This is all conjecture till whatever NR comes next. My hope would be FDA data or quarterly report first, assuming they have something positive.  Other experienced investors have already posted their concerns about this company today, which I share.   There's a lot of regurgitated hype and hope, which I've tuned out. Let's see what reality looks like.  Good luck with your future buy CAinPlap. 
<< Previous
Bullboard Posts
Next >>